$AGIO stock has now risen 11% today, according to our price data from Polygon. There has been approximately $20,404,252 of trading volume.
It has been the 903rd most-searched ticker on Quiver Quantitative over the last day, out of 11,939 total tickers searched.
Here is what we see in our data on $AGIO (you can track the company live on Quiver's $AGIO stock page):
$AGIO Insider Trading Activity
$AGIO insiders have traded $AGIO stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $AGIO stock by insiders over the last 6 months:
- BRIAN GOFF (Chief Executive Officer) has made 0 purchases and 4 sales selling 37,771 shares for an estimated $1,168,514.
- SARAH GHEUENS (Chief Medical Officer) has made 0 purchases and 4 sales selling 8,526 shares for an estimated $297,673.
- TSVETA MILANOVA (Chief Commercial Officer) has made 0 purchases and 3 sales selling 9,066 shares for an estimated $270,253.
- JAMES WILLIAM BURNS (Chief Legal Officer) has made 0 purchases and 2 sales selling 6,212 shares for an estimated $193,276.
- CECILIA JONES (Chief Financial Officer) has made 0 purchases and 2 sales selling 6,073 shares for an estimated $188,451.
- KRISHNAN VISWANADHAN (Chief Corp Dev & Strategy) has made 0 purchases and 2 sales selling 5,918 shares for an estimated $184,967.
- THEODORE JAMES JR. WASHBURN (Principal Accounting Officer) sold 5,272 shares for an estimated $152,255
- DAVID SCADDEN sold 200 shares for an estimated $8,768
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$AGIO Hedge Fund Activity
We have seen 133 institutional investors add shares of $AGIO stock to their portfolio, and 117 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BELLEVUE GROUP AG removed 3,714,736 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $101,115,113
- PARADIGM BIOCAPITAL ADVISORS LP removed 2,673,555 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $72,774,167
- COMMODORE CAPITAL LP removed 2,338,287 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $63,648,172
- ARMISTICE CAPITAL, LLC added 2,272,000 shares (+297.4%) to their portfolio in Q4 2025, for an estimated $61,843,840
- MACQUARIE GROUP LTD removed 1,958,101 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $53,299,509
- WELLINGTON MANAGEMENT GROUP LLP removed 1,873,590 shares (-75.8%) from their portfolio in Q4 2025, for an estimated $50,999,119
- D. E. SHAW & CO., INC. added 1,469,437 shares (+399.6%) to their portfolio in Q4 2025, for an estimated $39,998,075
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$AGIO Revenue
$AGIO had revenues of $20.7M in Q1 2026. This is an increase of 137.75% from the same period in the prior year.
You can track AGIO financials on Quiver Quantitative's AGIO stock page.
$AGIO Congressional Stock Trading
Members of Congress have traded $AGIO stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AGIO stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/03, 12/11 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
$AGIO Analyst Ratings
Wall Street analysts have issued reports on $AGIO in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Leerink Partners issued a "Outperform" rating on 12/26/2025
- B of A Securities issued a "Buy" rating on 12/24/2025
- Citigroup issued a "Buy" rating on 11/26/2025
- Truist Securities issued a "Buy" rating on 11/24/2025
- HC Wainwright & Co. issued a "Buy" rating on 11/20/2025
To track analyst ratings and price targets for $AGIO, check out Quiver Quantitative's $AGIO forecast page.
$AGIO Price Targets
Multiple analysts have issued price targets for $AGIO recently. We have seen 8 analysts offer price targets for $AGIO in the last 6 months, with a median target of $39.0.
Here are some recent targets:
- Greg Harrison from B of A Securities set a target price of $41.0 on 04/21/2026
- Emily Bodnar from HC Wainwright & Co. set a target price of $50.0 on 04/20/2026
- Tessa Romero from JP Morgan set a target price of $36.0 on 04/06/2026
- Salveen Richter from Goldman Sachs set a target price of $32.0 on 04/01/2026
- Samantha Semenkow from Citigroup set a target price of $46.0 on 03/05/2026
- Andrew Berens from Leerink Partners set a target price of $40.0 on 12/26/2025
- Gregory Renza from Truist Securities set a target price of $38.0 on 12/24/2025
You can track data on $AGIO on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
